Cardinal Health

Genstar Names Keith Martino to Strategic Advisory Board

Retrieved on: 
Martedì, Aprile 30, 2024
University, David G. Booth, Investment, SAB, Pharma, AbbVie, Central Waqf Council, Health, Cardinal Health, Partnership, Business, Genstar Capital, Genstar, SAN, Management

SAN FRANCISCO, April 30, 2024 /PRNewswire/ -- Genstar Capital, a leading private equity firm focused on investments in targeted segments of the healthcare, financial services, industrials, and software industries, today announced the appointment of experienced pharma executive Keith Martino to its team of operational experts serving on its Strategic Advisory Board. He will advise the Genstar team in its healthcare vertical.

Key Points: 
  • SAN FRANCISCO, April 30, 2024 /PRNewswire/ -- Genstar Capital, a leading private equity firm focused on investments in targeted segments of the healthcare, financial services, industrials, and software industries, today announced the appointment of experienced pharma executive Keith Martino to its team of operational experts serving on its Strategic Advisory Board.
  • Scott Niehaus, Director of Genstar Capital, said, "Keith is highly regarded in the pharma industry and has extensive background across the value chain including working with private equity.
  • We look forward to Keith's guidance in evaluating new healthcare investment opportunities and advising portfolio companies as a board member."
  • Mr. Martino was named to the Board of Genstar portfolio company Signant Health.

FDA Roundup: April 26, 2024

Retrieved on: 
Venerdì, Aprile 26, 2024
FDA, Lutetium (177Lu) oxodotreotide, Sale, Answer, Public, Report, Cosmetics, Syringe, Dietary supplement, News, Safety, DCM, Food, Research, Human services, GFI, Animal, Dilated cardiomyopathy, Cardinal Health, Commitment, Diabetes, Furosemide, Glomus tumor, Vaccine, Development, VFD, Osteoporosis, Novartis, BRAF, Inflammatory bowel disease, Tablet, Patient, Rheumatoid arthritis, Psoriasis, Heated tobacco product, Macular degeneration, Multimedia, Dog, Cancer, LGG, Food and Drug Administration, BRAF V600, Heart, Pharmaceutical industry

On Thursday, the FDA announced it has approved the first generic pimobendan for the management of congestive heart failure in dogs.

Key Points: 
  • On Thursday, the FDA announced it has approved the first generic pimobendan for the management of congestive heart failure in dogs.
  • The FDA expects this firm to fully address the violations described in the warning letter.
  • This represents the first FDA approval of a radioactive drug, or radiopharmaceutical, for pediatric patients 12 years of age and older with SSTR-positive GEP-NETs.
  • This represents the first FDA approval of a systemic therapy for the treatment of patients with pediatric LGG with BRAF rearrangements, including fusions.

Ilant Health Extends Seed Round to $5.5 Million, Attracting New Investors and Accelerating Growth

Retrieved on: 
Mercoledì, Aprile 17, 2024
Health, Health Technology, Practice Management, Fitness & Nutrition, General Health, Cardiology, Pillar, Highmark, Traction, Jess, Capital, Woman, Cardinal Health, Machine learning, Allegheny Health Network, Harvard Business School, Attention, NPS, Obesity, HPIR, Physician, Tenet Healthcare, Partner

Ilant Health , a pioneering leader in value-based obesity management and cardiometabolic health solutions, announced today the extension of its seed round of fundraising from $3 million to $5.5 million.

Key Points: 
  • Ilant Health , a pioneering leader in value-based obesity management and cardiometabolic health solutions, announced today the extension of its seed round of fundraising from $3 million to $5.5 million.
  • The decision to extend the seed round comes on the heels of Ilant’s accelerating traction due to its robust clinical model and proprietary analytics.
  • Notably, Ilant Health has garnered significant recognition, winning all three World 50 Group Academies — EHIR, HPIR, and PHIR, — and being selected for Highmark and Allegheny Health Network's accelerator, AlphaLab Health.
  • "AlphaLab Health looks for companies to solve problems facing healthcare today,” said Dr. Jeffrey Cohen, Chief Physician Executive at Allegheny Health Network.

AdaptHealth Appoints Suzanne Foster as Chief Executive Officer

Retrieved on: 
Mercoledì, Aprile 17, 2024
Nursing, Medical Supplies, Health, Medical Devices, Practice Management, Managed Care, Cardiology, Health policy, Danaher Corporation, Chairperson, Cardinal Health, Diabetes, History, Obesity, JD, Sleep apnea, Suffolk University Law School, Stanley Black & Decker, Harvard University, Growth, Management

AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that its Board of Directors has named Suzanne Foster as its Chief Executive Officer.

Key Points: 
  • AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that its Board of Directors has named Suzanne Foster as its Chief Executive Officer.
  • Ms. Foster will assume leadership of the Company from interim CEO and Chairman of the Board, Richard Barasch, on May 20, 2024.
  • Ms. Foster holds an MPH in Law and Health Policy from Harvard University and a JD from Suffolk University Law School.
  • We are grateful for his dedication to AdaptHealth and know he is delivering a healthy business to Suzanne.

GS1 Connect 2024 Agenda Offers Supply Chain Best Practices Across Retail, Grocery, Foodservice and Healthcare Industries

Retrieved on: 
Mercoledì, Aprile 24, 2024
EON, Supply, Target, Rothy's, The Coca-Cola Company, RFID, McDonald's, Fresenius (company), PepsiCo, Exhibition, Avery Dennison, Cardinal Health, Johnson & Johnson, Conference, Artificial intelligence, McKesson Corporation, Automation, GS1, Sustainability, Procter & Gamble, Bitly, Food, Salsify, SPS Commerce, Commerce, GS1 US, Digital, General Mills, Health, Management

EWING, NJ., April 24, 2024 /PRNewswire/ -- GS1 Connect 2024, the conference and exhibition hosted by GS1 US, will feature more than 300 leading companies that will share strategies for leveraging GS1 Standards to enable end-to-end supply chain visibility. Among the companies participating are Avery Dennison, BD, Bitly, Cardinal Health, Chick-fil-A, Dillard's, Fresenius Kabi, General Mills, Johnson & Johnson, Mars, McCormick & Company, McDonald's, McKesson, PepsiCo., Pfizer, Procter & Gamble, Target, Wegmans and more. The event will be held June 4-6, 2024, at the Orlando World Center Marriott in Orlando, Florida. To view the agenda, visit www.gs1us.org/gs1connect.

Key Points: 
  • The event will be held June 4-6, 2024, at the Orlando World Center Marriott in Orlando, Florida.
  • "GS1 Connect offers an unrivaled opportunity for industry members to learn about new developments and strategies that are driving visibility and optimization for an increasingly connected technology-driven world."
  • GS1 Connect is sponsored by 1WorldSync, Antares Vision Group, Avery Dennison, The Coca-Cola Company, Data Council + RIVIR, LSPedia, OPTEL, Salsify, SATO, Share-ify, SPS Commerce, Syndigo, and Trustwell.
  • To learn more about GS1 Connect 2024, visit www.gs1us.org/gs1connect .

Collective Healthcare Action to Reduce MedTech Emissions (CHARME) tackles emissions-intensive health care supply chain

Retrieved on: 
Martedì, Aprile 9, 2024
Health, Organization, Partnership, Cardinal Health, Hospital, Transport, Northwell Health, Accenture, Interim, Kaiser Permanente, Environmental health, Medtech, Renewable energy

OAKLAND, Calif., April 9, 2024 /PRNewswire/ -- The Collective Healthcare Action to Reduce MedTech Emissions (CHARME) collaborative launched today with the goal of reducing greenhouse gas emissions that arise from the multi-billion dollar U.S. medical device and equipment supply chain.  The MedTech (medical device, equipment, service, and distribution) supply chain accounts for 7% of U.S. health care greenhouse gas emissions. The Sustainable Purchasing Leadership Council is leading this effort in partnership with Kaiser Permanente and Vizient.

Key Points: 
  • OAKLAND, Calif., April 9, 2024 /PRNewswire/ -- The Collective Healthcare Action to Reduce MedTech Emissions (CHARME) collaborative launched today with the goal of reducing greenhouse gas emissions that arise from the multi-billion dollar U.S. medical device and equipment supply chain.
  • The MedTech (medical device, equipment, service, and distribution) supply chain accounts for 7% of U.S. health care greenhouse gas emissions.
  • CHARME fills a critical gap in existing decarbonization initiatives and has the potential to improve emission reductions in activities such as manufacturing and transportation practices across the MedTech supply chain.
  • The CHARME initiative will implement key findings from the white paper Catalyzing Collective Action to Decarbonize Healthcare Roadmap for Health Systems and MedTech Suppliers , which was published in 2023 by Kaiser Permanente, Health Care Without Harm, and Accenture, with input from over 30 organizations.

FourKites Named a Leader in the 2024 Gartner® Magic Quadrant™ for Fourth Consecutive Year

Retrieved on: 
Lunedì, Aprile 1, 2024
Technology, Retail, Other Transport, Trucking, Supply Chain Management, Rail, Maritime, Air, Transport, Other Technology, Other Retail, Software, Data Management, Logistics, Constellation, ETA, Completeness, Dow, ROI, Burn, Growth, Coca-Cola, Constellation Brands, Cardinal Health, RHI Magnesita, AI, Workplace, Yoy, Cargill, Magic

Leading real-time supply chain visibility company FourKites ® today announced that, for the fourth consecutive year, it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Real-Time Transportation Visibility Platforms (RTTVPs)* .

Key Points: 
  • Leading real-time supply chain visibility company FourKites ® today announced that, for the fourth consecutive year, it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Real-Time Transportation Visibility Platforms (RTTVPs)* .
  • Gartner evaluated seven vendors for its report, and FourKites has been recognized as a Leader both for its Ability to Execute and Completeness of Vision.
  • "We're honored to be recognized as a Leader by Gartner once again," said FourKites founder and CEO Mathew Elenjickal.
  • They have strategically expanded their offering to provide solutions that provide visibility to customer orders throughout the supply chain life cycle.”

FourKites Named a Leader in the 2024 Gartner® Magic Quadrant™ for Fourth Consecutive Year

Retrieved on: 
Martedì, Aprile 2, 2024
Software, Networks, Professional Services, Data Management, Technology, Artificial Intelligence, Other Transport, Data Analytics, Trucking, Maritime, Air, Transport, Logistics, Supply Chain Management, Constellation, ETA, Completeness, Dow, ROI, Burn, Growth, Coca-Cola, Constellation Brands, Cardinal Health, RHI Magnesita, AI, Workplace, Yoy, Cargill, Magic, Retail

Leading real-time supply chain visibility company FourKites ® today announced that, for the fourth consecutive year, it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Real-Time Transportation Visibility Platforms* (RTTVPs) .

Key Points: 
  • Leading real-time supply chain visibility company FourKites ® today announced that, for the fourth consecutive year, it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Real-Time Transportation Visibility Platforms* (RTTVPs) .
  • Gartner evaluated seven vendors for its report, and FourKites has been recognized as a Leader both for its Ability to Execute and Completeness of Vision.
  • "We're honored to be recognized as a Leader by Gartner once again," said FourKites founder and CEO Mathew Elenjickal.
  • They have strategically expanded their offering to provide solutions that provide visibility to customer orders throughout the supply chain life cycle.”

Cardinal Health announces location of pharmaceutical distribution center for over-the-counter products

Retrieved on: 
Martedì, Aprile 2, 2024
Automation, Growth, Partnership, Cardinal Health, Patient, SVP, CAH, Capitol Square, Cardinal, Warehouse

COLUMBUS, Ohio, April 2, 2024 /PRNewswire/ -- Today, Cardinal Health (NYSE: CAH) announced that construction has begun for a new 350,000 square-foot logistics center in Columbus, Ohio, that will serve as a centralized replenishment center for the distribution of over-the-counter consumer health products in support of its core pharmaceutical business.

Key Points: 
  • COLUMBUS, Ohio, April 2, 2024 /PRNewswire/ -- Today, Cardinal Health (NYSE: CAH) announced that construction has begun for a new 350,000 square-foot logistics center in Columbus, Ohio, that will serve as a centralized replenishment center for the distribution of over-the-counter consumer health products in support of its core pharmaceutical business.
  • Located in the Rickenbacker Global Logistics Park, the Consumer Health Logistics Center will be the fourth Cardinal Health distribution facility in Central Ohio, along with its corporate headquarters in Dublin, Ohio.
  • "Over the past five years, we've seen rapid growth in the demand for consumer health products," said Debbie Weitzman, CEO Pharmaceutical & Specialty Solutions.
  • "The innovative technology and solutions powering the Consumer Health Logistics Center will be a differentiator in the marketplace," stated Jamie Barker, SVP, Pharmaceutical Supply Chain.

Don Casey Joins Avista Capital Partners as a Strategic Executive

Retrieved on: 
Lunedì, Aprile 1, 2024
Avista Capital Partners, Cardinal Health, Growth, Medicine, Strategy, Health, Management

NEW YORK, April 1, 2024 /PRNewswire/ -- Avista Capital Partners ("Avista"), a leading New York-based private equity firm focused exclusively on healthcare, today announced that Don Casey has joined the firm as a Strategic Executive.

Key Points: 
  • NEW YORK, April 1, 2024 /PRNewswire/ -- Avista Capital Partners ("Avista"), a leading New York-based private equity firm focused exclusively on healthcare, today announced that Don Casey has joined the firm as a Strategic Executive.
  • Mr. Casey most recently served as the Chief Executive Officer of Dentsply Sirona, the world's largest manufacturer of professional dental products and technologies.
  • Mr. Casey has more than 30 years of global healthcare experience and an outstanding track record of identifying and commercializing successful medical innovations.
  • Don Casey, Strategic Executive at Avista Capital Partners said, "I have long admired Avista Capital and their outstanding reputation in the healthcare space.